A detailed history of Aquilo Capital Management, LLC transactions in Repare Therapeutics Inc. stock. As of the latest transaction made, Aquilo Capital Management, LLC holds 956,932 shares of RPTX stock, worth $3.43 Million. This represents 3.16% of its overall portfolio holdings.

Number of Shares
956,932
Previous 633,271 51.11%
Holding current value
$3.43 Million
Previous $2.98 Million 5.87%
% of portfolio
3.16%
Previous 2.33%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$3.02 - $4.7 $977,456 - $1.52 Million
323,661 Added 51.11%
956,932 $3.16 Million
Q4 2023

Feb 14, 2024

BUY
$3.22 - $11.79 $2.04 Million - $7.47 Million
633,271 New
633,271 $4.62 Million

Others Institutions Holding RPTX

About Repare Therapeutics Inc.


  • Ticker RPTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,937,800
  • Market Cap $150M
  • Description
  • Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...
More about RPTX
Track This Portfolio

Track Aquilo Capital Management, LLC Portfolio

Follow Aquilo Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aquilo Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aquilo Capital Management, LLC with notifications on news.